A new tool called fetalHQ on GE Healthcare’s Voluson ultrasound systems is the first tool to simultaneously examine the size, shape and function of the fetal heart.
The U.S. Food and Drug Administration (FDA) and the U.S. Department of Homeland Security (DHS) will be implementing a new framework for greater coordination and cooperation between the two agencies for addressing medical device cybersecurity. The partnership is part of a memorandum of agreement the two agencies issued this month.
Blood pressure readings of 130/80 millimeters of mercury (mmHg) or higher taken at home can be used to diagnose hypertension in white, black and Hispanic U.S. adults, according to new research in the American Heart Association’s journal Hypertension.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, is pausing the CONCERT-HF trial, which involves patients with chronic heart failure. Recent calls for the retraction of journal articles in related fields of cell therapy research have raised concerns about the scientific foundations of this trial, according to the NHLBI.
October 29, 2018 — Good Samaritan Hospital recently became the first hospital on the West Coast to utilize the Carto ...
Hitachi Healthcare Americas participated in the cardiovascular screening and diagnostic triage event that took place across four clinical sites in the greater Morgantown, W. V. on Oct. 20, 2018. This event provided 375 rural patients a resource for diagnostic screening not normally available in their region.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians determine whether someone is having a heart attack. New data, published online in JAMA Cardiology, found a new blood test under development that is done right at the patient's side in as little as 15 minutes could identify nearly three-fifths (56.7 percent) of people at low risk of experiencing a heart attack. The results are similar to the results of a High Sensitive Troponin-I blood test done in the laboratory setting.
Eko, creators of a machine learning-based heart and lung monitoring platform, announced a collaboration with Mayo Clinic to develop a data-driven technology to help physicians detect potentially dangerous heart diseases that may otherwise be missed. The two entities will work together to develop and commercialize a machine learning-based algorithm with a smart digital stethoscope that screens patients for the presence of a low ejection fraction. Once identified, evidence-based treatments are available that prolong life and reduce the risk of symptoms.
Overall cardiology compensation has dropped for the first time since 2014, according to the sixth annual Cardiovascular Provider Compensation & Production Survey from MedAxiom. In addition, the survey found the income gap between private and integrated groups widened in 2017.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
October 25, 2018 — On Oct. 18, 2018, LivaNova issued a Medical Device Correction letter to inform customers of actions ...
Pre-participation physical evaluations (PPEs) are a standard requirement for many school-aged athletes to participate in competitive sports. One purpose of the PPE is to check for any underlying cardiovascular abnormalities that could put an athlete at risk for sudden cardiac arrest (SCA), which is the number one medical cause of death in young athletes.
Michael Flaherty, M.D., discusses a study published in Circulation Research which finds that use of hemodynamic support ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes-related complications such as heart attacks, blindness and coma. Researchers from the University of Missouri School of Medicine and the Massachusetts Institute of Technology (MIT) recently evaluated the accuracy of an MIT-developed technology to monitor blood glucose levels without needles or a finger prick. Early results show the noninvasive technology measures blood glucose levels as effectively as a finger-prick test — without drawing blood.
Health informatics company Impathiq announced its Heart Pathway point-of-care clinical decision support tool was recently featured in the American Heart Association journal Circulation. The article, “Safely Identifying Emergency Department Patients with Acute Chest Pain for Early Discharge: The HEART Pathway Accelerated Diagnostic Protocol” appeared Sept. 28 in Circulation.
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease risk assessment, according to a new study appearing in the journal Radiology.